Serum antibody response to the gH/gL/pUL128-131 five-protein complex of human cytomegalovirus (HCMV) in primary and reactivated HCMV infections

Journal of Clinical Virology

Volumn 52, Issue 2, 2011, Pages 113-118

  Genini, Emilia ^a   Percivalle, Elena ^a   Sarasini, Antonella ^a   Revello, M Grazia ^a   Baldanti, Fausto ^a   Gerna, Giuseppe ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

ELISA; GH gL pUL128 131 complex; HCMV; IgG antibody; Primary infection; Vaccine

Indexed keywords

ADENOVIRUS VECTOR; ANTIBODY; GENE PRODUCT; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; VIRUS GLYCOPROTEIN;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN BLOOD LEVEL; NONHUMAN; PRIMARY INFECTION; PRIORITY JOURNAL; VIRUS NEUTRALIZATION;

ADENOVIRIDAE; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, VIRAL; GENETIC VECTORS; HEK293 CELLS; HUMANS; IMMUNOGLOBULIN G; MEMBRANE GLYCOPROTEINS; TRANSDUCTION, GENETIC; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS;

EID: 80052714529     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2011.06.018     Document Type: Article

References (25)

1. Hahn G., Revello M.G., Patrone M., Percivalle E., Campanini G., Sarasini A., et al. Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. J Virol 2004, 78:10023-10033.
2. Wang D., Shenk T. Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism. J Virol 2005, 79:10330-10338.
3. Wang D., Shenk T. Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. Proc Natl Acad Sci USA 2005, 102:18153-18158.
4. Ryckman B.J., Rainish B.L., Chase M.C., Borton J.A., Nelson J.A., Jarvis M.A., et al. Characterization of the human cytomegalovirus gH/gL/UL128-131 complex that mediates entry into epithelial and endothelial cells. J Virol 2008, 82:60-70.
5. Huber M.T., Compton T. The human cytomegalovirus UL74 gene encodes the third component of the glycoprotein H-glycoprotein L-containing envelope complex. J Virol 1998, 72:8191-8197.
6. Ryckman B.J., Chase M.C., Johnson D.C. Human cytomegalovirus TR strain glycoprotein O acts as a chaperone promoting gH/gL incorporation into virions but is not present in virions. J Virol 2010, 84:2597-2609.
7. Wille P.T., Knoche A.J., Nelson J.A., Jarvis M.A., Johnson D.C. A human cytomegalovirus gO-null mutant fails to incorporate gH/gL into the virion envelope and is unable to enter fibroblasts and epithelial and endothelial cells. J Virol 2010, 84:2585-2596.
8. Eggers M., Metzger C., Enders G. Differentiation between acute primary and recurrent human cytomegalovirus infection in pregnancy, using a microneutralization assay. J Med Virol 1998, 56:351-358.
9. Eggers M., Bäder U., Enders G. Combination of microneutralization and avidity assays: improved diagnosis of recent primary human cytomegalovirus infection in single serum sample of second trimester pregnancy. J Med Virol 2000, 60:324-330.
10. Eggers M., Radsak K., Enders G., Reschke M. Use of recombinant glycoprotein antigens gB and gH for diagnosis of primary human cytomegalovirus infection during pregnancy. J Med Virol 2001, 63:135-142.
11. Schoppel K., Schmidt C., Einsele H., Hebart H., Mach M. Kinetics of the antibody response against human cytomegalovirus-specific proteins in allogeneic bone marrow transplant recipients. J Infect Dis 1998, 178:1233-1243.
12. Gerna G., Sarasini A., Patrone M., Percivalle E., Fiorina L., Campanini G., et al. Human cytomegalovirus serum neutralizing antibodies block virus infection of endothelial/epithelial cells, but not fibroblasts, early during primary infection. J Gen Virol 2008, 89:853-865.
13. Cui X., Meza B.P., Adler S.P., Mc Voy M.A. Cytomegalovirus vaccines fail to induce epithelial entry neutralizing antibodies comparable to natural infection. Vaccine 2008, 26:5760-5766.
14. Saccoccio F.M., Sauer A.L., Cui X., Armstrong A.E., Habib E-SE, Johnson D.C. Peptides from cytomegalovirus UL130 and UL131 proteins induce high titer antibodies that block viral entry into mucosal epithelial cells. Vaccine 2011, 29:2705-2711.
15. Revello M.G., Zavattoni M., Sarasini A., Percivalle E., Simoncini L., Gerna G. Human cytomegalovirus in blood of immunocompetent persons during primary infection: prognostic implications for pregnancy. J Infect Dis 1998, 177:1170-1175.
16. Revello M.G., Genini E., Gorini G., Klersy C., Piralla A., Gerna G. Comparative evaluation of eight commercial human cytomegalovirus IgG avidity assays. J Clin Virol 2010, 48:255-259.
17. Revello M.G., Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev 2002, 15:680-715.
18. Gerna G., Lilleri D., Fornara C., Comolli G., Lozza L., Campana C., et al. Monitoring of human cytomegalovirus-specific CD4+ and CD8+ T cell immunity in patients receiving solid organ transplantation. Am J Transplant 2006, 6:2356-2364.
19. Heim A., Ebnet C., Harste G., Pring-Akerblom P. Rapid and quantitative detection of human adenovirus DNA by real-time PCR. J Med Virol 2003, 70:228-239.
20. Gerna G., Revello M.G., Percivalle E., Morini F. Comparison of different immunostaining techniques and monoclonal antibodies to the lower matrix phosphoprotein (pp65) for optimal quantitation of human cytomegalovirus antigenemia. J Clin Microbiol 1992, 30:1232-1237.
21. Macagno A., Bernasconi N.L., Vanzetta F., Dander E., Sarasini A., Revello M.G., et al. Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128-131A complex. J Virol 2010, 84:1005-1013.
22. Gerna G., Baldanti F., Percivalle E., Zavattoni M., Campanini G., Revello M.G. Early identification of human cytomegalovirus strains by the shell vial assay is prevented by a novel amino acid substitution in UL123 IE1 gene product. J Clin Microbiol 2003, 41:4494-4495.
23. Revello M.G., Gerna G. Maternal, fetal and neonatal diagnosis of congenital human cytomegalovirus infection. Expert Opin Med Diagn 2008, 2:547-563.
24. Lilleri D., Gerna G., Fornara C., Lozza L., Maccario R., Locatelli F. Prospective simultaneous quantification of human cytomegalovirus-specific CD4+ and CD8+ T-cell reconstitution in young recipients of allogeneic hematopoietic stem cell transplants. Blood 2006, 108:1406-1412.
25. Nigro G., Adler S.P., La Torre R., Best A.M. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 2005, 353:1350-1362. the Congenital Cytomegalovirus Collaborating Group.